| Name | Title | Contact Details |
|---|
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
McBride Consulting, LLC, is a minority and Service-Disabled Veteran-Owned Small Business (SDVOSB) management consulting and project management firm with significant professional services experience that includes business strategy development, finance, accounting and audit readiness support, information security controls, business process optimization, human capital management and operations.
American Business Development Corporation (ABD) helps B2B service providers build scalable, high-impact business development (BD) operations. We specialize in structuring BD strategies, aligning marketing and outreach efforts, and securing key partnerships to drive growth. Whether through a customized Business Development Plan®, implementing BD processes, or serving as an outsourced BD team, ABD ensures companies have the tools, strategy, and execution needed to expand their client pipeline and increase revenue. ABD was founded on the belief that business development is built on relationships, not automation. We dont rely on spam emails or impersonal outreach. Instead, we focus on strategic engagement, tailored messaging, and real human connections to generate high-quality leads and long-term partnerships. Our expertise spans industries such as life sciences, medical devices, professional services, and international trade, helping companies break into new markets and optimize BD functions. For companies expanding into the U.S. market, ABD provides outsourced BD solutions, acting as a dedicated U.S.-based BD team. We represent companies at key industry conferences, execute outreach on partnering platforms, conduct meetings, and manage post-conference follow-up—ensuring that warm, engaged leads are seamlessly transferred to the clients internal team. This eliminates costly international travel while maximizing business development opportunities. ABD also supports export strategies, helping companies expand into foreign markets through strategic partnerships, trade mission planning, and regulatory alignment. With over 20 years of international economic development experience, we connect businesses with high-value clients and funding opportunities through government agencies, accelerators, and industry leaders. At ABD, we dont just generate leads—we build long-term, sustainable BD operations that drive growth beyond our engagement.
LTCG is a leading provider of business process outsourcing for the insurance industry. The nations largest insurers rely on our unparalleled expertise to help manage their complex long-term care portfolios and maximize financial performance. We also provide clients with advanced risk management insight built upon our unique and proprietary long-term care underwriting and claims databases. LTCG has more than 1.4 million long-term care policies currently under its management, representing nearly 20% of all active policies. We serve over 50 national carriers, including every one of the top 10 insurers in the long-term care market. Our experienced management team, which has worked together for years, includes some of the most recognized and respected leaders in the long-term care industry. And our information systems have been developed specifically to support the intricacies of this unique market. To learn more, visit www.ltcg.com